Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 26, 2026

New Crypto Pepeto Advances DeFi Tools While Bitcoin Price Target $180,000 and Whales Load Next Dogecoin

View original at globenewswire.com
New Crypto Pepeto Advances DeFi Tools While Bitcoin Price Target $180,000 and Whales Load Next Dogecoin Dubai, UAE, July 26, 2026 (GLOBE NEWSWIRE) -- Pepeto is preparing a revolution in DeFi trading with its zero-fee exchange, and the timing is making considering presales, the crypto side that hands most of returns dur…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Truth API is priced at up to $100,000 per month, with a $60,000 rate for three-year commitments.

    60% confidence
  • $1,000 invested in Dogecoin in March 2020 became $365,000 by May 2021, a 365x return.

    60% confidence
  • A sitting congressman is asking regulators whether selling early access to presidential posts breaks manipulation rules.

    60% confidence
  • Bitcoin price prediction target of $180,000.

    60% confidence
  • The president's social media posts move markets, so market participants pay for early access.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
New Crypto Pepeto Advances DeFi Tools While Bitcoin Price Target $180,000 and Whales Load Next Dogecoin — Source | Via News | ViaNews Market